Jinglu Lyu

State Key Laboratory Of Oral Diseases
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Salivary pathobiont Klebsiella pneumoniae exacerbating periodontitis-related intestinal dyshomeostasis and accelerated metabolic syndrome.

Salivary pathobiont Klebsiella pneumoniae exacerbating periodontitis-related intestinal dyshomeostasis and accelerated metabolic syndrome.

Journal: Molecular immunology
Published: December 16, 2025

Oral-gut axis in inflammation: periodontitis exacerbates ulcerative colitis via microbial dysbiosis and barrier disruption.

Oral-gut axis in inflammation: periodontitis exacerbates ulcerative colitis via microbial dysbiosis and barrier disruption.

Journal: BMC oral health
Published: April 02, 2025

HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.

HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.

Journal: Molecular immunology
Published: December 03, 2022

Oral Microbiota from Periodontitis Promote Oral Squamous Cell Carcinoma Development via γδ T Cell Activation.

Oral Microbiota from Periodontitis Promote Oral Squamous Cell Carcinoma Development via γδ T Cell Activation.

Journal: mSystems
Published: August 24, 2022

Beware of pharyngeal Fusobacterium nucleatum in COVID-19.

Beware of pharyngeal Fusobacterium nucleatum in COVID-19.

Journal: BMC microbiology
Published: June 23, 2021

Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker.

Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker.

Journal: Journal of applied microbiology
Published: February 07, 2021

The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro.

The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro.

Journal: International immunopharmacology
Published: January 13, 2021

Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?

Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?

Journal: Medical hypotheses
Published: April 10, 2020

Human β-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages.

Human β-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages.

Journal: Molecular immunology
Published: February 12, 2017

β-defensin 3 modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharide.

β-defensin 3 modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharide.

Journal: Cytokine
Published: November 25, 2016

Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide.

Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide.

Journal: International immunopharmacology
Published: December 19, 2015

Human β-defensin 3 suppresses Porphyromonas gingivalis lipopolysaccharide-induced inflammation in RAW 264.7 cells and aortas of ApoE-deficient mice.

Human β-defensin 3 suppresses Porphyromonas gingivalis lipopolysaccharide-induced inflammation in RAW 264.7 cells and aortas of ApoE-deficient mice.

Journal: Peptides
Published: December 11, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026